| (in millions $) | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1886.82 | $1893.79 | $1385.51 | |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $3.87 | $3.52 | $3.33 | $1.68 |
| Goodwill & intangible assets | $194.04 | $190.46 | $189.98 | |
| Total noncurrent assets | ||||
| Total investments | $13028.65 | $13452.81 | $13999.41 | |
| Total assets | $11355.55 | $15467.34 | $15847.66 | $15798.01 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $139.92 | $181.71 | $107.86 | $39.51 |
| Long term debt | $15.86 | $15.86 | $15.85 | $15.85 |
| Total noncurrent liabilities | ||||
| Total debt | $715.86 | $815.85 | $815.85 | |
| Total liabilities | $10752.33 | $14136 | $14424.44 | $14251.52 |
| Shareholders' equity | ||||
| Retained earnings | -$754.8 | $295.12 | $254.47 | $218.56 |
| Other shareholder equity | -$199.33 | -$520.09 | -$386.2 | -$225.93 |
| Total shareholder equity | $1331.35 | $1423.22 | $1546.5 | |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5387.95 | $2962.09 | $133.6 | |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | $3.87 | $3.01 | $2.07 | $7.83 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | $10473.82 | $2597.68 | $1972.97 | |
| Total assets | $11355.55 | $16005.5 | $5586.23 | $2128.13 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $139.92 | $97 | $13 | $14 |
| Long term debt | $15.86 | $16 | $15.83 | $19.53 |
| Total noncurrent liabilities | ||||
| Total debt | $15.85 | $15.83 | $73.41 | |
| Total liabilities | $10752.33 | $14396.66 | $5291.94 | $1897.09 |
| Shareholders' equity | ||||
| Retained earnings | -$754.8 | $193.86 | $118.35 | $92.31 |
| Other shareholder equity | -$199.33 | -$6.92 | $46.04 | $6.4 |
| Total shareholder equity | $1608.84 | $294.3 | $231.04 | |
| (in millions $) | 31 Jan 2023 | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | -$833.58 | $79.76 | ||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$24.34 | $10.6 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | -$1049.92 | $38.6 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | -$604.53 | $90.8 | $87.15 | |
| Cost of revenue | ||||
| Gross Profit | $90.8 | $87.15 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $52.11 | $45.69 | ||
| Total operating expenses | $59.6 | $52.48 | ||
| Operating income | $31.19 | $34.67 | ||
| Income from continuing operations | ||||
| EBIT | $31.19 | $34.67 | ||
| Income tax expense | $6.74 | $5.16 | $9.83 | |
| Interest expense | $7.23 | $10.08 | ||
| Net income | ||||
| Net income | -$948.66 | $26.04 | $24.85 | |
| Income (for common shares) | $26.04 | $24.85 | ||
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $43.33 | $38.6 | $27.39 | $21.39 |
| Operating activities | ||||
| Depreciation | $0.9 | $0.81 | $0.81 | $0.72 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.08 | $1.02 | $0.73 | $0.56 |
| Total cash flows from operations | $100.3 | $155.21 | $13.64 | -$39.37 |
| Investing activities | ||||
| Capital expenditures | -$4.21 | -$0.98 | -$58.68 | -$1.66 |
| Investments | $261.64 | $253.83 | -$3859.91 | -$1510.06 |
| Total cash flows from investing | $257.43 | $251.14 | -$3918.59 | -$1511.72 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.29 | $0.06 | -$0.03 | $530.66 |
| Net borrowings | -$100 | $800 | ||
| Total cash flows from financing | -$364.69 | $101.93 | -$97.49 | $3154.55 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$6.96 | $508.28 | -$4002.44 | $1603.46 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $78.53 | $26.04 | $24.85 | $22.33 |
| Operating activities | ||||
| Depreciation | $2.62 | $5.58 | $2.67 | $1.18 |
| Business acquisitions & disposals | $47.39 | |||
| Stock-based compensation | $1.93 | $0.88 | $0.18 | $0.11 |
| Total cash flows from operations | $79.76 | -$479.31 | -$126.86 | -$3.07 |
| Investing activities | ||||
| Capital expenditures | -$1.92 | -$0.92 | -$1.21 | -$2.66 |
| Investments | -$7981.61 | -$69.84 | -$620.68 | -$203.97 |
| Total cash flows from investing | -$7983.54 | -$70.58 | -$574.5 | -$206.63 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1099.74 | $0.04 | $6.46 | $96.63 |
| Net borrowings | -$51.79 | $47.86 | -$16.14 | |
| Total cash flows from financing | $10329.64 | $3378.38 | $160.55 | $86.45 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2425.86 | $2828.48 | -$540.82 | -$123.25 |
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 31.66M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |